Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. Approximately 12-18% of colorectal carcinomas show MSI. MSI is the result of defects in genes hMLH1, hMSH2, hPMS1, hPMS2 and GTBP/hMSH6. [1] Tumours which have MSI are called MSI-H. MSI-H tumours are significant predictors of disseminated disease in colorectal cancer. [2] Tumours on the right side of colon (caecum/ascending colon), those in patients younger than 50 years and those with medullary or signet ring morphology are suggestive of mismatch repair (MMR) loss and should be screened for MMR proteins by immunohistochemistry (IHC). The results of IHC should be interpreted and subsequently followed up as follows:
• All four proteins are present and there is no family history (80% of total cases): Stop further testing.
• MLH 1 and PMS 2 are absent (15% of total cases):
Check for BRAF mutation analysis: If present, stop testing: If negative, sequence for gene rearrangement.
• MSH 2 and/or MSH 6 absent (5% of total cases):
Sequence for gene rearrangement.
Positive staining demonstrates that the tumour is negative for MSI. A negative staining would mean tumour is MSI high or microsatellite unstable. 
